FINWIRES · TerminalLIVE
FINWIRES

European Wind Power Developers Face Higher Prices, Supply Constraints, Says Rystad Energy

By

-- Europe's offshore wind expansion ambition are running up against turbine supply constraints as well as rising prices in a market increasingly reliant on a concentrated group of manufacturers, Rystad Energy said on Wednesday.

Siemens Gamesa and Vestas products are basically the only product options available to European developers since GE Vernova (GEV) paused new order intake due to operational setbacks, Rystad said.

Rystad has found that turbine selling prices have risen between 40% and 45% since 2020, well in excess of manufacturing cost increases of 20% to 25% since then.

The manufacturing cost increases come down to the turbines' most technically complex components such as the nacelle that contained the generator, gearbox and power electronics. There are also growing pressures within blade manufacturing, Rystad's research notes.

Rystad said the result of the equipment supply bottleneck is that progress on deployment of this form of renewable power is now at least as much decided by equipment availability as it is down to political ambition.

The research said that high demand, a limited supplier base and the growing complexity of turbines means that manufacturers have "real pricing power and the ability to be selective about which projects get built."

Rystad concluded that Europe needed to expand manufacturing capacity or find workarounds to this set of problems otherwise it will face missing its 2030 targets for renewable energy and pay more for capacity it does install.

The note says that larger 14 megawatt to 15 MW turbines have been dominant among recent deliveries to offshore projects, eclipsing those of 9-10 MW capacity.

Rystad's research shone a light on a less evident trend beyond component costs, highlighting that some of their price hikes are reactionary, after manufacturers got somewhat burned by fixed-price supply contracts entered into immediately before a period of higher inflation.

In a seller's market, manufacturers no longer feel pressure to assume such risks through that contract model and are passing more of future cost increases on to developers, Rystad said.

Related Articles

Mining & Metals

RBC Maintains Suncor Energy's Outperform Rating, C$100 Price Target

RBC Capital Markets on Wednesday reiterated Suncor Energy's (SU.TO) outperform rating and C$100 price target, with the bank noting the company delivered another quarter of "robust performance" punctuated by a "jumbo-sized" downstream pre-tax margin of $2 billion (including FIFO gains) in part driven by record refined product sales of 680,900 bbl/d.RBC's updated production outlook of 862,100 bbl/d, anchored by a $5.7 billion capital program, remains relatively unchanged."Suncor's first-quarter results reinforced our confidence that its culture of sustained high performance is taking deep root and enabling the company to be on the podium, come what may," RBC said. "We believe the ingredients are in place for the company to earn a premium relative valuation, conceivably over the next year," RBC added.Suncor is RBC's favorite integrated producer in Canada and is part of its Global Energy Best Ideas list.Suncor traded at $85.70 per share at last look Thursday on the Toronto Stock Exchange.Price: $85.70, Change: $-2.21, Percent Change: -2.51%

$SU.TO
Australia

RBC Capital Adjusts VSE Price Target to $240 From $220, Maintains Outperform Rating

VSE (VSEC) has an average rating of Buy and mean price target of $248.50, according to analysts polled by FactSet.Price: $206.85, Change: $-0.60, Percent Change: -0.29%

$VSEC
Australia

RBC Capital Adjusts United Therapeutics Price Target to $701 From $707, Maintains Outperform Rating

United Therapeutics (UTHR) has an average rating of buy and mean price target of $670.67, according to analysts polled by FactSet.Price: $585.63, Change: $-11.14, Percent Change: -1.87%

$UTHR